Mounia Chaoui-Roulleau

Develops software, digital tools and technology for the physical engineering & product development sectors

Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases

Develops & discovers CNS drug candidates

Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic

Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases

Sofimac Innovation is an active manager which prefers to invest equity to create or grow limited liability companies in the ICT sector. The firm invests principally in France and Western European countries because they believe that geographical proximity between investee companies and their team is necessary to provide effective support. Sofimac Innovation typically invests €0.5-€1.5 million in the first round in early-stage companies and €0.5-€3 million with co-investors in subsequent rounds when necessary. The firm works in partnership with their investee companies, providing expertise to support them in assessing and positioning their new technology in their competitive environment, measuring and developing the managing team's potential for success and building the foundations that will allow the company to transform the initial concept into reality. Sofimac Innovation aims to invest in companies which have a technological innovation with growth potential, a quality management team, technological intensity and barriers to entry (including intellectual property rights ownership), a large target market with significant growth potential, a robust marketing strategy and a project in its final stage of development.

Provides management consulting services

Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million.

Ventech invests in companies located in Europe, primarily in France, Germany, the DACH region, the Nordics region and the United States. The firm focuses on a broad range of sectors and industries. It participates in pre-seed, seed and early stage capital requirements with an investment size of EUR 0.15 - 5 million.